Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05820659 · ClinicalTrials.gov registry record · NA

Racial Discrimination and Stress Response

A NA study, sponsored by Western Kentucky University.

Completed
Registry status
NA
Development phase
144
Enrollment target

NCT05820659: Completed NA study, sponsored by Western Kentucky University.

NCT05820659 is a NA study that has completed, run by Western Kentucky University. The registered enrollment target is 144 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05820659, a NA study, has completed, sponsored by Western Kentucky University.

COMPLETED
Registry status
NA
Development phase
144 participants
Enrollment target

Study Summary

The goal of this study is to learn about whether ethnic minority adolescents' racial discrimination experience is related to dysregulated biological responses to subtle racism, and how the relationship may be attenuated or exacerbated by a set of social and cognitive factors. The main questions it aims to answer are: * to reveal the relationship between racial discrimination experiences and ethnic minority adolescents' stress response to subtle racism * to test parental ethnic-racial socialization, children's attribution to subtle racism and their racial identity as potential risk and protective factors.

Primary Outcome

adolescents' diastolic and systolic blood pressure will be continuously monitored.

Interventions

  • BEHAVIORAL peer rejection task and impossible puzzle task

Trial Details

FieldValue
Enrollment Target 144 participants
Start Date 2023-06-29
Est. Completion 2024-11-17
Phase NA
Western Kentucky University

10 total trials

What the finished NCT05820659 record still lists

NCT05820659 is an interventional study that assigns participants to a tested intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 1 intervention - of which peer rejection task and impossible puzzle task is the first listed.

NCT05820659 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05820659 about?

NCT05820659 is a clinical study titled "Racial Discrimination and Stress Response". The goal of this study is to learn about whether ethnic minority adolescents' racial discrimination experience is related to dysregulated biological responses to subtle racism, and how the relationship may be attenuated or exacerbated by a set of social and cognitive factors. The main questions it a...

What is the current status of trial NCT05820659?

This trial is currently completed. It is a NA study. The enrollment target is 144 participants. The study started on 2023-06-29. Estimated completion is 2024-11-17.

What interventions are being tested in trial NCT05820659?

The interventions under investigation include: peer rejection task and impossible puzzle task (BEHAVIORAL).

Who is sponsoring clinical trial NCT05820659?

This trial is sponsored by Western Kentucky University, which has 10 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05820659's enrollment target sits among peer trials

144 706th of 2000 higher than 1,290 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01861106 · 144 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

  • NCT03482245 · 144 participants · NA

    The Role of Circadian Clock Proteins in Innate and Adaptive Immunity

  • NCT03504683 · 144 participants · NA

    MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes

  • NCT03905603 · 144 participants · Early Phase 1

    Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05820659, the US trial registry maintained by the National Library of Medicine. NCT05820659 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.